Market Cap

Liquidia Corp Market Capitalization:

€2.61 Billion

EUR as of Jan. 1, 2026

US$3.06 Billion

business Liquidia Corp Company Profile

Liquidia Corp Main Stock Listing

FSX: LT4

Market Capitalization History of Liquidia Corp

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Liquidia Corp market cap

Date Market Cap YoY Change
Jan. 1, 2026 €2.61 B 131.85%
Jan. 1, 2025 €1.12 B 46.21%
Jan. 1, 2024 €768.8 M 92.01%
Jan. 1, 2023 €400.4 M 20.68%
Jan. 1, 2022 €331.8 M 109.57%
Jan. 1, 2021 €158.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Liquidia Corp Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Liquidia Corp has the following listings and related stock indices.


Stock: FSX: LT4

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.